CYCLOPHOSPHAMIDE for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 5 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE was used for Hypercholesterolaemia.
Most Reported Side Effects for CYCLOPHOSPHAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 12,578 | 9.8% | 2,788 | 3,928 |
| Febrile neutropenia | 11,318 | 8.8% | 1,348 | 7,223 |
| Drug ineffective | 8,142 | 6.3% | 2,157 | 2,184 |
| Neutropenia | 7,352 | 5.7% | 1,287 | 2,890 |
| Disease progression | 7,100 | 5.5% | 1,730 | 1,008 |
| Pyrexia | 6,126 | 4.8% | 832 | 4,228 |
| Product use in unapproved indication | 5,750 | 4.5% | 1,245 | 1,392 |
| Thrombocytopenia | 4,669 | 3.6% | 902 | 1,799 |
| Pneumonia | 4,595 | 3.6% | 1,633 | 2,604 |
| Nausea | 4,561 | 3.6% | 363 | 2,190 |
| Anaemia | 4,486 | 3.5% | 664 | 2,040 |
| Death | 4,270 | 3.3% | 4,260 | 453 |
| Sepsis | 4,041 | 3.1% | 2,077 | 1,841 |
| Myelosuppression | 3,603 | 2.8% | 209 | 1,796 |
| Diarrhoea | 3,602 | 2.8% | 566 | 1,861 |
Other Indications for CYCLOPHOSPHAMIDE
Diffuse large b-cell lymphoma (16,598)
Plasma cell myeloma (9,148)
Breast cancer (8,826)
Product used for unknown indication (8,261)
Acute lymphocytic leukaemia (5,495)
B-cell lymphoma (4,766)
Bone marrow conditioning regimen (4,485)
Non-hodgkin's lymphoma (3,805)
Chemotherapy (3,372)
Chronic lymphocytic leukaemia (3,085)
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)